Age is one of the strongest risk factors for cancer and also affects tumour biology, treatment recommendations and response to therapy. Although clinical oncology guidelines advocate against classifying patients on the basis of chronological age alone, most studies and published guidelines use discrete age cutoffs, often heterogeneously. Herein, we discuss age cutoffs from a historical and biological perspective, focusing on breast cancer.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Carleton, N. et al. Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women. Lancet Healthy Longev. 3, e54–e66 (2022).
Van Herck, Y. et al. Is cancer biology different in older patients? Lancet Healthy Longev. 2, e663–e677 (2021).
Biganzoli, L. et al. Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG). Lancet Oncol. 22, e327–e340 (2021).
Gradishar, W. J. et al. Breast cancer, version 3.2022, NCCN Clinical practice guidelines in oncology. J. Natl. Compr. Canc. Netw. 20, 691–722 (2022).
Dotan, E. et al. NCCN Guidelines® insights: older adult oncology, version 1.2021. J. Natl. Compr. Canc. Netw. 19, 1006–1019 (2021).
Frequently Asked Questions, Age 65 Retirement. US Social Security Administration https://www.ssa.gov/history/age65.html (2022).
Shah, Y. et al. Pan-cancer analysis reveals molecular patterns associated with age. Cell Rep. 37, 110100 (2021).
Furman, D. et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 25, 1822–1832 (2019).
Sayed, N. et al. An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging. Nat Aging 1, 598–615 (2021).
Ludmir, E. B. et al. Factors associated with age disparities among cancer clinical trial participants. JAMA Oncol. 5, 1769–1773 (2019).
Acknowledgements
N.C. receives funding from the National Cancer Institute of the National Institutes of Health (award number 1F30CA264963-01).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Carleton, N., McAuliffe, P.F. Are the chronological age cutoffs used in clinical oncology guidelines biologically meaningful?. Nat Rev Clin Oncol 19, 745–746 (2022). https://doi.org/10.1038/s41571-022-00684-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-022-00684-4
